نتایج جستجو برای: ژن kras

تعداد نتایج: 23037  

2013
Ibrahim Halil Sahin Syed M.A. Kazmi Jeffrey T. Yorio Nishin A. Bhadkamkar Bryan K. Kee Christopher R. Garrett

KRAS mutations occur frequently in colorectal cancers (CRC) and predict lack of response to anti-epidermal growth factor receptor (EGFR) monoclonal antibody therapy. CRC BRAF mutations, most commonly at V600E, occur less than 10% of the time, and occur usually in KRAS wild-type tumors, and more frequently in microsatellite instable tumors. Concomitant KRAS and BRAF mutant CRCs are rare (occurri...

2013
Peter M. K. Westcott Minh D. To

Mutational activation of KRAS is a common oncogenic event in lung cancer and other epithelial cancer types. Efforts to develop therapies that counteract the oncogenic effects of mutant KRAS have been largely unsuccessful, and cancers driven by mutant KRAS remain among the most refractory to available treatments. Studies undertaken over the past decades have produced a wealth of information rega...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2010
Hans Prenen Sabine Tejpar Eric Van Cutsem

The introduction of new cytotoxic agents and new targeted therapies has significantly broadened the therapeutic options for and the outcomes of patients with metastatic colorectal cancer (CRC). The introduction of the anti-epidermal growth factor receptor (EGFR) antibodies, cetuximab and panitumumab, has clearly contributed to this development. The concept of KRAS as a marker for resistance to ...

2015
Valerie R Wiersma Marco de Bruyn Yunwei Wei Robert J van Ginkel Mitsuomi Hirashima Toshiro Niki Nozomu Nishi Jin Zhou Simon D Pouwels Douwe F Samplonius Hans W Nijman Paul Eggleton Wijnand Helfrich Edwin Bremer

Oncogenic mutation of KRAS (Kirsten rat sarcoma viral oncogene homolog) in colorectal cancer (CRC) confers resistance to both chemotherapy and EGFR (epidermal growth factor receptor)-targeted therapy. We uncovered that KRAS mutant (KRAS(mut)) CRC is uniquely sensitive to treatment with recombinant LGALS9/Galectin-9 (rLGALS9), a recently established regulator of epithelial polarity. Upon treatme...

2016
Christopher J. Tape Stephanie Ling Maria Dimitriadi Kelly M. McMahon Jonathan D. Worboys Hui Sun Leong Ida C. Norrie Crispin J. Miller George Poulogiannis Douglas A. Lauffenburger Claus Jørgensen

Oncogenic mutations regulate signaling within both tumor cells and adjacent stromal cells. Here, we show that oncogenic KRAS (KRAS(G12D)) also regulates tumor cell signaling via stromal cells. By combining cell-specific proteome labeling with multivariate phosphoproteomics, we analyzed heterocellular KRAS(G12D) signaling in pancreatic ductal adenocarcinoma (PDA) cells. Tumor cell KRAS(G12D) eng...

Journal: :Cancer research 2010
Shuangni Yu Zhaohui Lu Changzheng Liu Yunxiao Meng Yihui Ma Wugan Zhao Jianping Liu Jia Yu Jie Chen

Therapeutic applications of microRNA (miRNA) in KRAS-driven pancreatic cancers might be valuable, but few studies have explored this area. Here, we report that miR-96 directly targets the KRAS oncogene and functions as a tumor-suppressing miRNA in pancreatic cancer cells. Ectopic expression of miR-96 through a synthetic miRNA precursor inhibited KRAS, dampened Akt signaling, and triggered apopt...

Journal: :Cell 2012
Haoqiang Ying Alec C. Kimmelman Costas A. Lyssiotis Sujun Hua Gerald C. Chu Eliot Fletcher-Sananikone Jason W. Locasale Jaekyoung Son Hailei Zhang Jonathan L. Coloff Haiyan Yan Wei Wang Shujuan Chen Andrea Viale Hongwu Zheng Ji-hye Paik Carol Lim Alexander R. Guimaraes Eric S. Martin Jeffery Chang Aram F. Hezel Samuel R. Perry Jian Hu Boyi Gan Yonghong Xiao John M. Asara Ralph Weissleder Y. Alan Wang Lynda Chin Lewis C. Cantley Ronald A. DePinho

Tumor maintenance relies on continued activity of driver oncogenes, although their rate-limiting role is highly context dependent. Oncogenic Kras mutation is the signature event in pancreatic ductal adenocarcinoma (PDAC), serving a critical role in tumor initiation. Here, an inducible Kras(G12D)-driven PDAC mouse model establishes that advanced PDAC remains strictly dependent on Kras(G12D) expr...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2015
Frank McCormick

KRAS proteins play a major role in human cancer, but have not yielded to therapeutic attack. New technologies in drug discovery and insights into signaling pathways that KRAS controls have promoted renewed efforts to develop therapies through direct targeting of KRAS itself, new ways of blocking KRAS processing, or by identifying targets that KRAS cancers depend on for survival. Although drugs ...

Journal: :The Journal of Cell Biology 2005
Marc Fivaz Tobias Meyer

The Ras/MAPK pathway regulates synaptic plasticity and cell survival in neurons of the central nervous system. Here, we show that KRas, but not HRas, acutely translocates from the plasma membrane (PM) to the Golgi complex and early/recycling endosomes in response to neuronal activity. Translocation is reversible and mediated by the polybasic-prenyl membrane targeting motif of KRas. We provide e...

Journal: :Cancer discovery 2014
Zehua Zhu Amir R Aref Travis J Cohoon Thanh U Barbie Yu Imamura Shenghong Yang Susan E Moody Rhine R Shen Anna C Schinzel Tran C Thai Jacob B Reibel Pablo Tamayo Jason T Godfrey Zhi Rong Qian Asher N Page Karolina Maciag Edmond M Chan Whitney Silkworth Mary T Labowsky Lior Rozhansky Jill P Mesirov William E Gillanders Shuji Ogino Nir Hacohen Suzanne Gaudet Michael J Eck Jeffrey A Engelman Ryan B Corcoran Kwok-Kin Wong William C Hahn David A Barbie

Although the roles of mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K) signaling in KRAS-driven tumorigenesis are well established, KRAS activates additional pathways required for tumor maintenance, the inhibition of which are likely to be necessary for effective KRAS-directed therapy. Here, we show that the IκB kinase (IKK)-related kinases Tank-binding kinase-1 (TBK...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید